Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07164404 · ClinicalTrials.gov registry record · NA

Nicotine Replacement Therapy Prescribing and Lung Cancer Screening in Hospitalized Patients

A NA study of Tobacco Use Disorder, sponsored by Medical University of South Carolina.

Active
Registry status
NA
Development phase
220
Enrollment target
1
Study location

NCT07164404 is a NA study of Tobacco Use Disorder that is active but no longer recruiting, run by Medical University of South Carolina. The registered enrollment target is 220 participants, roughly in line with the 236-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07164404, a NA study of Tobacco Use Disorder, is active but no longer recruiting, sponsored by Medical University of South Carolina.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
220 participants
Enrollment target
1
Study location

Study Summary

Investigators are evaluating an EHR-based, non-interruptive alert to increase NRT prescribing in the hospital and at discharge for hospitalized patients. Investigators will investigate two randomized groups of resident physicians to evaluate their prescribing behaviors when the tool is introduced.

Conditions Studied

Interventions

  • OTHER EHR alert

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 220 participants
Start Date 2025-11-17
Est. Completion 2026-04
Phase NA

What the Registry Record Tells You About NCT07164404

The ClinicalTrials.gov registry entry for NCT07164404 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 236-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Tobacco Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which EHR alert is the first listed.

NCT07164404 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT07164404 about?

NCT07164404 is a clinical study titled "Nicotine Replacement Therapy Prescribing and Lung Cancer Screening in Hospitalized Patients". Investigators are evaluating an EHR-based, non-interruptive alert to increase NRT prescribing in the hospital and at discharge for hospitalized patients. Investigators will investigate two randomized groups of resident physicians to evaluate their prescribing behaviors when the tool is introduced.

What is the current status of trial NCT07164404?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 220 participants. The study started on 2025-11-17. Estimated completion is 2026-04.

What conditions does trial NCT07164404 study?

This clinical trial studies the following conditions: Tobacco Use Disorder.

What interventions are being tested in trial NCT07164404?

The interventions under investigation include: EHR alert (OTHER).

Who is sponsoring clinical trial NCT07164404?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07164404 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.